In brief: Schizophrenia and the metabolic syndrome

In Brief

Schizophrenia and the metabolic syndrome

Published: October, 2006

Results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study show that people with schizophrenia, especially women, are exceptionally vulnerable to the metabolic syndrome.

This set of health risks includes at least three of the following:

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »